326 related articles for article (PubMed ID: 35142639)
1. America's HIV Epidemic Analysis Dashboard: Protocol for a Data Resource to Support Ending the HIV Epidemic in the United States.
Sullivan PS; Woodyatt CR; Kouzouian O; Parrish KJ; Taussig J; Conlan C; Phillips H
JMIR Public Health Surveill; 2022 Feb; 8(2):e33522. PubMed ID: 35142639
[TBL] [Abstract][Full Text] [Related]
2. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Adults With Diagnosed HIV Living in Ending the HIV Epidemic Priority Areas, Medical Monitoring Project, 2018.
Chowdhury PP; Beer L; Crim SM; Bosh KA; Desamu-Thorpe RG; Shouse LR
Public Health Rep; 2023; 138(1):107-113. PubMed ID: 35137642
[TBL] [Abstract][Full Text] [Related]
4. Examination of Incidence of Sexually Transmitted Infections in the Ending the HIV Epidemic Priority Counties of the United States, 2005-2019.
Bunting SR; Hunt B; Johnson AK; Hazra A; Nunez-Garcia A; Glick N
Sex Transm Dis; 2024 Mar; 51(3):139-145. PubMed ID: 38100791
[TBL] [Abstract][Full Text] [Related]
5. HIV Testing in 50 Local Jurisdictions Accounting for the Majority of New HIV Diagnoses and Seven States with Disproportionate Occurrence of HIV in Rural Areas, 2016-2017.
Pitasi MA; Delaney KP; Brooks JT; DiNenno EA; Johnson SD; Prejean J
MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(25):561-567. PubMed ID: 31246940
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan.
Tatapudi H; Gopalappa C
BMC Med Res Methodol; 2022 Nov; 22(1):304. PubMed ID: 36435750
[TBL] [Abstract][Full Text] [Related]
7. Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals.
Jenness SM; Johnson JA; Hoover KW; Smith DK; Delaney KP
AIDS; 2020 Nov; 34(14):2103-2113. PubMed ID: 32910062
[TBL] [Abstract][Full Text] [Related]
8. A Data Visualization and Dissemination Resource to Support HIV Prevention and Care at the Local Level: Analysis and Uses of the AIDSVu Public Data Resource.
Sullivan PS; Woodyatt C; Koski C; Pembleton E; McGuinness P; Taussig J; Ricca A; Luisi N; Mokotoff E; Benbow N; Castel AD; Do AN; Valdiserri RO; Bradley H; Jaggi C; O'Farrell D; Filipowicz R; Siegler AJ; Curran J; Sanchez TH
J Med Internet Res; 2020 Oct; 22(10):e23173. PubMed ID: 33095177
[TBL] [Abstract][Full Text] [Related]
9. How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?
Mitchell KM; Maheu-Giroux M; Dimitrov D; Moore M; Hughes JP; Donnell D; Beyrer C; El-Sadr WM; Cohen MS; Boily MC
Clin Infect Dis; 2022 Aug; 75(1):163-169. PubMed ID: 34849635
[TBL] [Abstract][Full Text] [Related]
10. Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.
Jacobson EU; Hicks KA; Carrico J; Purcell DW; Green TA; Mermin JH; Farnham PG
J Acquir Immune Defic Syndr; 2022 Apr; 89(4):374-380. PubMed ID: 35202046
[TBL] [Abstract][Full Text] [Related]
11. Addressing Racism's Role in the US HIV Epidemic: Qualitative Findings From Three Ending the HIV Epidemic Prevention Projects.
Harrison SE; Muessig K; Poteat T; Koester K; Vecchio A; Paton M; Miller SJ; Pereira N; Harris O; Myers J; Campbell C; Hightow-Weidman L
J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S46-S55. PubMed ID: 35703755
[TBL] [Abstract][Full Text] [Related]
12. What Will It Take to End HIV in the United States? : A Comprehensive, Local-Level Modeling Study.
Fojo AT; Schnure M; Kasaie P; Dowdy DW; Shah M
Ann Intern Med; 2021 Nov; 174(11):1542-1553. PubMed ID: 34543589
[TBL] [Abstract][Full Text] [Related]
13. New pathogen, same disparities: why COVID-19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic.
Millett GA
J Int AIDS Soc; 2020 Nov; 23(11):e25639. PubMed ID: 33222424
[TBL] [Abstract][Full Text] [Related]
14. Profile of the Portfolio of NIH-Funded HIV Implementation Research Projects to Inform Ending the HIV Epidemic Strategies.
Queiroz A; Mongrella M; Keiser B; Li DH; Benbow N; Mustanski B
J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S23-S31. PubMed ID: 35703752
[TBL] [Abstract][Full Text] [Related]
15. Estimating HIV Incident Diagnoses Among Men Who Have Sex With Men Eligible for Pre-exposure Prophylaxis but Not Taking It: Protocol and Feasibility Assessment of Data Sources and Methods.
Sullivan PS; Hall E; Bradley H; Sanchez T; Woodyatt CR; Russell ES
JMIR Res Protoc; 2023 Mar; 12():e42267. PubMed ID: 36881450
[TBL] [Abstract][Full Text] [Related]
16. Roles for Pharmacists in the "Ending the HIV Epidemic: A Plan for America" Initiative.
McCree DH; Byrd KK; Johnston M; Gaines M; Weidle PJ
Public Health Rep; 2020; 135(5):547-554. PubMed ID: 32780671
[TBL] [Abstract][Full Text] [Related]
17. Geographic variations of pre-exposure prophylaxis reversal and abandonment among United States counties.
Dawit R; Goedel WC; Reid SC; Doshi JA; Nunn AS; Chan PA; Dean LT
AIDS; 2024 Mar; 38(4):557-566. PubMed ID: 37976040
[TBL] [Abstract][Full Text] [Related]
18. Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America.
Moore M; Boily MC; Mitchell KM; Donnell DD; Cohen MS; Dimitrov DT
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):395-398. PubMed ID: 33136735
[TBL] [Abstract][Full Text] [Related]
19. The importance of local epidemic conditions in monitoring progress towards HIV epidemic control in Kenya: a modelling study.
Anderson SJ; Garnett GP; Enstone J; Hallett TB
J Int AIDS Soc; 2018 Nov; 21(11):e25203. PubMed ID: 30485720
[TBL] [Abstract][Full Text] [Related]
20. Ending the HIV Epidemic: New York's Quest to Become the First State to Reduce HIV Prevalence.
Morne JE; Tesoriero JM; Martin EG; Birkhead GS; Holtgrave DR; Hagos K; Zucker H
Public Health Rep; 2020; 135(1_suppl):65S-74S. PubMed ID: 32735198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
